For instance, low doses of an anti-VEGFR2 antibody could normalize breast tumor vasculature, redirect tumor-associated macrophages to an immune stimulatory M1-like phenotype and increase T cell tumor infiltration (252). Here, KDR is linked to breast neoplasm.